TEL AVIV, Israel, April 7, 2020 /PRNewswire/ — Alpha Tau Medical– the developer of breakthrough alpha-radiation cancer therapy Alpha DaRT, and Medison Canada – a fully owned subsidiary of Medison Pharma, are pleased to announce that they have entered into an exclusive distribution arrangement.

Read more here.